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Abstract  
Background: There is a need for improved psychosocial interventions for distressed 
voice hearers.  
Aims: To evaluate a novel approach to hearing voices: Experience Focussed 
Counselling (EFC) aka Making Sense of Voices. 
Study design and methods: 12 voice hearers were randomly assigned to a 44-week 
EFC or Treatment As Usual intervention as part of a pilot study design.  
Results: At the end of intervention EFC showed clinically large treatment effect 
improvements on the Brief Psychiatric Rating Scale – Expanded Version psychotic 
symptoms (Cohen’s d=1.6) and overall psychopathology domains (d=1.3), and the 
Psychotic Symptom Rating Scales voices (d=1) and delusions (aka non-shared reality) 
(d=1) scales. EFC voice hearers also felt more able to do first trauma disclosures (n=4) 
than TAU group voice hearers (n=1).   
Discussion: EFC improvements may have been related to the focus on reducing voices 
related distress. EFC holds some promise as a safe and effective intervention for voice 
hearers, with possible improvements in general psychopathology, psychosis, voices, 
and non-shared reality (aka delusions) related distress. This will need replicating in 
more powerful studies. 
 
Keywords: hearing voices, psychosis, schizophrenia, Making Sense of Voices, Experience 
Focussed Counselling (EFC), randomised controlled trial (RCT), Hearing Voices Movement 
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Introduction  
The need for a change in approach to the way distressed voice hearer(s) (VH) experience 
mental health services remains strongly supported by VH themselves, especially via the fast 
growing international Hearing Voices Movement (HVM) (Corstens, Longden, McCarthy-
Jones, Waddingham & Thomas, 2014).  
Short- and long-term side-effects of antipsychotic medication, including higher mortality rates 
(Aderhold & Stastny, 2007), and atypical antipsychotics only producing 18% better clinical 
response rates than placebo (Leucht, Arbter, Engel, Kissling & Davis, 2009) challenge the 
current dominance of medicalised approaches in routine psychiatric provision. Whilst a small 
majority recover clinically from schizophrenia, it remains unclear what helps in this process. 
A difficult to measure personal process of recovery appears more meaningful though 
necessitates a paradigm shift in psychiatric service provision (Slade, Amering & Oades, 2008; 
Dillon, Johnstone & Longden, 2012). An approach like CBT in Psychosis (CBTp) is currently 
modest in effectiveness (Wykes, Steel, Everitt & Tarrier, 2008). There is thus an on-going 
need to improve recovery rates and personal experience of recovery in current psychiatric 
provision.  
Importantly, the individualised approach of the HVM, Experience Focussed Counselling 
(EFC) aka Making Sense of Voices (Romme & Escher, 2008), remains largely absent from 
mainstream mental health services. This may in part be the result of EFC not claiming to be a 
standardised or manualised intervention, as well as the use of less traditional sources of 
evidence (Schnackenberg & Martin, 2014). These contain primarily anecdotal stories of 
personal recovery (Romme, Escher, Corstens, Dillon & Morris, 2009); a self-selecting trans-
diagnostic sample of n=100 using aspects of the Making Sense of Voices approach (Corstens 
& Longden, 2013); and a convenience sample of n=27 finding beneficial effects in an 
anxiety-depression domain (Casstevens, Cohen, Newman, & Dumaine, 2006), using a 
workbook (Coleman & Smith, 1997).  
This study therefore set out to evaluate a pilot randomised controlled trial (RCT) of EFC to 
highlight important issues of feasibility and safety for future research designs.  
Qualitative results of the overall mixed-methods design were considered separately in line 
with a conceptual triangulation approach (Guest, MacQueen & Namey, 2012). 
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Methods  
 
Design 
Treatment As Usual (TAU) was compared with EFC in routine psychiatric settings over a 
period of 44 weeks, a practice-based estimate of the time needed to potentially complete an 
EFC process. The overall research aims focussed on evaluating EFC’s 1) applicability across 
diagnoses; 2) its relative value in improving primary and secondary clinical distress and 
recovery measures; 3) its ability to help understand and work on unresolved problems in a 
person’s life. The study concentrated on the feasibility of recruitment, randomisation, 
retention, assessment, study design methods, and novel EFC interventions employed. Some 
initial hypothesis testing provided early indications regarding the safety, efficacy and 
effectiveness of EFC (Arain, Campbell, Cooper & Lancaster, 2010).  
 
Participants 
Inclusion criteria reflected concerns about using scientifically contested diagnostic concepts 
such as schizophrenia (Bentall, 2009), and the fact that voice hearing is experienced across 
diagnoses (Aleman & Laroi, 2008). A symptom, or experience, focus was used instead. Using 
the language of experience instead of symptom, voice hearing instead of auditory 
hallucination, and non-shared reality instead of delusions respectively, was also expressing 
the non-pathologising paradigm of the HVM ethos (Romme, 2009).  
 
Participant inclusion criteria were:  
1) 18 – 65 years of age 
2) Voice hearing distress levels of a ≥4 severity rating on the Brief Psychiatric Rating 
Scale – Expanded Version (BPRS-E) hallucination item, in line with needs-based 
psychosis definitions (Bak et al., 2003).  
3) VH did not have to identify themselves as voice hearers (Romme & Escher, 2008). 
Experiences had to be audible, without a clear external source (Haddock, 2009). 
4) Any or no psychiatric diagnosis.  
5) No alcohol or drug abuse in the past 3 months.  
6) No organic brain disease or diagnosis of dementia.  
7) IQ over 70.  
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Recruitment 
Recruitment of smaller numbers to complex psychosocial interventions like CBTp (Lynch, 
Laws & McKenna, 2010) or Open-Dialogue (Seikkula, Alakare & Aaltonen, 2011) is not 
unusual.  
A 4-year period of varied recruitment efforts by the first author saw two psychiatric services 
provide a mixed sample: the St Ansgar gGmbH in the North of Germany; and the 
Pfalzklinikum in the South West of Germany. Following a brief study information session by 
the first author, local mental health professionals (MHP) were asked to inform and invite 
potentially interested VH. VHs’ fear of medication increases and extensions of psychiatric 
support should they talk openly about voices, as well as the randomised design, hampered 
potential participation.  
 
Sampling 
N=42 VH were screened, n=29 met inclusion criteria, n=22 finally agreed to continue with the 
study following randomisation. Reasons given by the n=7 VH not to continue with the study 
following randomisation, were: 1) a fear of not being discharged if they talked about voices 
(n=1); 2) only wanting to take part in the opposite groups to the respective groups they had been 
randomised into (n=2 and n=1 respectively); 3) dying of a heart attack, despite being below 30 
years of age (n=1); 4) focussing on a new relationship instead (n=1); 5) no reasons given (n=1).  
 
Interventions 
Both groups continued to have access to all normal TAU interventions. MHP were asked to 
spend a flexible 45 – 60 minutes one-to-one time with the VH on 2 – 3 occasions per month to 
allow for clinical variations and to control for non-specific intervention effects (Valmaggia, 
van der Gaag, Tarrier, Pijnenborg & Sloof, 2005). The main difference between the groups 
was therefore the respective focus of one-to-one conversations. The EFC group focussed on 
EFC interventions and the TAU group on providing generic support as described below.  
 
EFC 
EFC denotes a mutual process of making sense of the voice hearing experience within the 
person’ s life context (Corstens & Longden, 2013), and of supporting the VH in learning to 
better deal with the experience as part of a recovery process (Corstens, Escher & Romme, 
2009). In EFC voices also express a normal human experience which at best needs to be given 
6 
This is an Accepted Manuscript of an article published by Taylor & Francis in Psychosis on [5 Jul 
2016], available online: http://www.tandfonline.com/10.1080/17522439.2016.1185452. 
the chance to be socially and individually emancipated (Romme, Honig, Noorthorn & Escher, 
1992) but must certainly not be cured. Pathologising language would therefore be 
inappropriate in this context (Romme, 2009).  
Participating MHPs were given written guidance based on the theory by Romme & Escher 
(2008), additional HVM practice-based insights (Corstens et al., 2014) and the practice 
experience by the first author of the study. They were asked to engage in the sequential use of 
EFC tools such as the Maastricht Interview, Report and Construct, alongside the development 
of HVM-suggested coping strategies, including voice dialogue (Corstens, Longden & May, 
2012). These tools, when employed creatively and yet in a structured manner, aid the process 
of bringing order, life context, and increasing calmness to what can often be experienced as a 
very chaotic and anxiety provoking experience of voice hearing. Attempting to answer 1) 
who(m) and 2) what problems the voices represent within a summarised outline of life 
context, completes the process as part of a Construct development (Corstens, Escher & 
Romme, 2009).  
Importantly, the EFC approach, whilst frequently uncovering traumatic life connections to 
voices (Corstens et al., 2014), is marked by an attitude of working within the explanatory 
system of the VH. The process should also be VH-led and ideas or processes should not be 
imposed (Romme & Escher, 2008).  
 
Training in EFC 
EFC delivering MHP were trained in the application of EFC tools via a 3-level progressing 
training programme (total of 6 days) which ran alongside the first 6 months of the study with 
three months in between levels. Individual interventions started following the first training 
level.  
In line with HVM principles, EFC group VH could and did take part in some or all of the EFC 
training at n=5, n=6, n=5 for the three levels respectively. A predictably varied attendance 
amounted to m=46.35% of the total time across workshops. MHP’s EFC taught material 
comprehension was tested via 10 and 11 items multiple choice tests, including theory and a 
practice video at the end of respective training levels. Excellent (k≥0.75) (Coolican, 2009) 
Cohen’s KAPPA interrater reliability at k=0.96; k=0.93; and k=0.92 were reached, thus 
contributing to intervention fidelity.  
EFC training was delivered by three experienced EFC trainers of the EFC Institute (EFC 
training organisation based in Germany), including a recovering VH. The first author of this 
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article was one of the EFC trainers (having been trained and supervised by Coleman, 
Corstens, Romme & Escher among others) with several years experience of providing EFC 
supervision and training. He had also been applying EFC in a variety of routine acute and 
community mental health settings since the year 2000.  
 
TAU 
TAU generally comprised of antipsychotic medication, general rehabilitative life skills 
support and techniques for the distraction from voices or challenging beliefs, thus 
representing a classic mainstream biological model psychiatric approach. 
 
Counsellors/Accompaniers 
Using the term counsellor or accompanier highlighted that therapy is not what EFC is about, 
even if it may have therapeutic or distress alleviating benefits. The interventions were 
delivered by experienced staff (paedagoges, nurses, psychologists, social workers). They were 
all new to EFC. EFC supervision ensured intervention fidelity and was offered via one-to-one 
and group supervision by the first author. It amounted to an average of m=8.57 minutes/week 
(s.d.=4.37) per MHP. 
 
Ethical Approval 
Informed consent of participants was obtained prior to the study. University of the West of 
Scotland and local ethical approvals were gained between June 2011 and December 2012. 
The study took place between August 2011 and January 2014.  
 
Randomisation 
Participants were randomised in blocks of 2 (1 control group; 1 intervention group). Thus, 
where possible, every participating MHP had one person to support in the intervention and 
one in the control group respectively, to minimise therapist-specific effects (Valmaggia et al., 
2005).  
 
Outcome Measures 
Assessment periods covered the last 7 days respectively. Apart from satisfactory to good 
reliability and validity criteria, choice of primary and secondary outcome measures aimed to 
afford comparability with related studies and address current discussions on recovery and 
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psychosis, as well as the hypothesised potential impact of voice hearing distress on other 
domains or their relevance in influencing voice hearing distress (Romme & Escher, 2008).  
 
Primary Measures 
The BPRS-E (Ventura et al., 1993) is a general psychopathology 24-item, 1 – 7 point Likert 
scale, outcome measure, with no-predetermined subscale structure. Ratings of ≥4 are 
considered clinically relevant. To determine which factorial solution to use in the analysis of 
this study’s results, a review confirmed its use in psychosis related research and identified the 
4-factor solution by Velligan et al. (2005), with its trans-diagnostic focus, which included 
similar diagnoses to this study’ s sample.  
Voice hearing dimensions were addressed with the Psychotic Symptom Rating Scales 
(PSYRATS) auditory hallucinations (voices) scale (Haddock, McCarron, Tarrier & Faragher, 
1999; Haddock, 2009), which has been commonly used in VH related research. It consists of 
11 items with ratings from 0 (no distress) – 4 (very distressed) and there are no fixed clinical 
cut off points.  
The Questionnaire about the Process of Recovery (QPR) (Neil et al., 2009) is a 22-item self-
completion scale, consisting of an interpersonal and intrapersonal subscale. It was jointly 
developed with people in recovery from psychosis experiences. Scoring ranges from 0 
(disagree strongly) – 4 (agree strongly) with higher scores indicative of greater recovery.   
 
Secondary Measures 
As a result of the word limit, only clinically significant and relevant findings could be 
included in this article.  
 
Rater Training 
Raters were compared to gold-standard ratings and trained prior to the study to excellent 
(k≥0.75) (Coolican, 2009) inter-rater agreements on the BPRS-E (k=0.90), the PSYRATS 
(k=0.82), and the SAI-E (k=0.95). 
 
Translation Process 
Employing a panel of experts process (Harkness, 2003), the main author of this study 
translated both small necessary updates (two primary measures) and all of the remaining 
scales completely, apart from the already translated secondary HADS and HAq-II measures.  
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Statistics 
Data Collection 
There were three post-baseline assessment points, coinciding with the points in time prior to 
the respective EFC training workshops II (3 months), and III (6 months) and at the end of 
treatment at 44 weeks. Assessments were conducted by the respective MHP delivering the 
intervention, as identifying and engaging in the full extent of the voice hearing experience 
was best considered possible within a trusted, non-pathologising relationship (Romme, 2009). 
Whilst blinding is difficult to achieve in reality as language used might unintentionally betray 
VH group allocation (Turkington, Kingdon, & Weiden, 2006), it has the advantage of 
reducing potential raters’ bias and social desirability responses by participants, as evidenced 
by lowered effect sizes in blinded CBTp trials (Wykes et al., 2008). Given the feasibility 
focus of this study, participant safety and trust appeared to outweigh study design purity at 
that stage, and a non-blinding process was therefore chosen.  
 
Statistical Analyses 
All statistical analyses were conducted using the Statistical Package for the Social Sciences 
(SPSS) 20 and 22, alongside Microsoft Excel for effect size and sample size calculations.  
 
Data Analyses Employed 
Although the small sample size would only allow for indications rather than the ability to 
provide firm conclusions on evidence, statistical tests would allow for an indication whether 
bigger samples might indeed achieve a treatment effect in future studies. A mixed 2 (group: 
EFC, TAU) x 4 (time: baseline, 3-months, 6-months, 44-weeks) repeated measures Analyses 
of Variance (ANOVA) tested for overall significance (α=0.05). Treatment effect sizes were 
calculated using Cohen´s d ((mean difference of experimental group – mean difference of 
control group)/pooled s.d) (McGough & Faraone, 2009), supported by confidence interval 
calculations (Howell, 2010) and complemented by paired t-tests.   
Missing data were followed up and a Complete Cases Analysis was conducted.  
 
Results  
Engagement in Study 
Only n=12 completed all 3 post-baseline assessment point measures, due to staff shortages 
(n=4), staff sickness (n=2), moving house (n=1), no benefits felt (n=3 TAU clients).  
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Independent t-tests of baseline outcome and demographic measures comparing completers 
with non-completers, and the n=5 participants/group not completing their respective 
intervention group confirmed attrition bias was kept low (Dumville, Torgerson & Hewitt, 
2006).   
One EFC group VH moved away before completing the final set of self-completion scales, 
leading to a reduction of n=1 in these scales.   
Due to staffing and sickness problems, one-to-one time amounted to m=10.21, s.d.=5.64 (EFC 
group) and m=9, s.d.=17.10 (TAU group) minutes/week, instead of the suggested minimum 
m=20.78 minutes/week. 
Engagement in EFC was characterised by an initial hesitation by some VH participants, as 
they feared increases in medication, hospital stays, a pathologisation of their experiences, and 
looking more closely at anxiety provoking and personal experiences. However, both MHP 
and VH reported benefiting from, and appreciating, this way of engaging as very relevant.  
 
Sample Description 
A series of independent t-tests of outcome measures at baseline between EFC and TAU group 
confirmed a largely successful randomisation. Participating clients were not significantly 
different in terms of age, gender, length of continuous psychiatric contact, total admissions, 
primary diagnosis, time since diagnosis (table 1), ethnicity, marital, employment, housing 
status, first psychiatric contact, last year’s number of admissions, and secondary diagnosis 
(unpublished data). Number of antipsychotics and Chlorpromazine equivalent doses were a 
lot higher than recommended for maintenance treatment (table 1).  
As a next step, analysing potential improvements would help to address EFC effectiveness 
(research question 2) but also EFC’s potential trans-diagnostic applicability (research question 
1). 
 
Table 1 EFC and TAU background characteristics 
 
Primary Outcomes 
The time x group interaction effect was significant in the BPRS-E psychosis subscale 
(F(3,30)=5.37, p=.004, ES=.349) and, using the Greenhouse-Geisser Epsilon, nearly 
significant in the BPRS-E total scale (F(1.75,17.51)=3.50, p=.058, ES=.259).  
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Paired t-test and treatment effect size analyses (table 2) confirmed directional a priori 
hypotheses of greater EFC improvements and the findings of the ANOVA. The BPRS-E total 
scale highlighted statistically significant within EFC group improvements at the 3-months 
(p=.012 (one-tailed)) and 44-weeks (p=.013 (one-tailed)) time points. Similar improvements 
were again noted in the BPRS-E psychosis factor at the 3-months (p=.009 (one-tailed)) and 
the 44-weeks (p=.012 (one-tailed)) time points. These findings were further substantiated by 
large (d≥0.8) treatment effect size improvements (range of d=0.9 – d=1.7) for both scales 
throughout the study. Of note were also the EFC group treatment effect improvements on the 
BPRS-E anxiety and depression domain, which were large (d=1.2) at 3-months, and medium 
(d=0.6) at 44 weeks. The BPRS-E negative symptoms and activation factor showed no 
clinically relevant trend (unpublished results). Importantly, the PSYRATS voices scale 
steadily improved towards a large treatment effect at the end of the study (d=1.0). 
Interestingly, the QPR revealed an increasing not significant endorsement of intrapersonal 
aspects of recovery in the EFC group, whilst the TAU group tentatively suggested a need for 
greater interpersonal aspects of recovery across time points (unpublished results). 
 
Table 2 Primary outcomes 
 
Secondary Outcomes 
At the end of treatment, there were large EFC group treatment effect improvements on the 
PSYRATS delusions (aka non-shared reality) scale (d=1.0) (with n=4 for both groups); the 
MHLC-C (locus of control) chance subscale (Wallston, Stein & Smith, 1994) (d=1.2); as well 
as small reductions (d=0.4) in Chlorpromazine equivalent use and less days spent in hospital 
than the TAU group (d=0.6). 5 EFC participants completed the Maastricht Interview, 4 the 
Maastricht Report, and 2 the Maastricht Construct. Importantly, 57% (n=4) in the EFC group 
and only 20% (n=1) in the TAU group disclosed traumatic experiences for the first time.  
 
Discussion 
Limitations 
The small sample size, the pilot nature of this study, the use of measuring tools not yet 
validated in German and the lack of blinding were obvious limitations of the study. Findings 
can thus only provide some initial support towards EFC being applicable across diagnoses, 
and effective in improving general psychopathology, psychosis, voice hearing related (table 
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2), and non-shared reality distress, as well as the lessening of the locus of control chance 
element. The use of frontline practitioners, provided early evidence of EFC’s potential value 
in routine psychiatric practice settings in contrast to other interventions’ (i.e. CBTp) often 
more artificial research designs (Thomas, 2015). 
As this study had controlled for counsellor-specific factors, non-specific intervention effects, 
and antipsychotic medication use, a more likely explanation for EFC improvements, also 
supported by the qualitative study (unpublished results), which, too, addressed the above 
stated research aims, might be the EFC group’s focus on reducing voices related distress with 
a potential effect on locus of control and general psychopathology, too. Encouragingly, 
relatively high baseline distress levels and being part of long-term rehabilitative settings did 
not prevent positive engagement and improvements.   
Importantly, EFC improvements took place despite a higher number of first trauma 
disclosures, suboptimum provision of one-to-one support and a minimum level of supervision 
only.  
 
Feasibility 
Given that no EFC group VH left the study or relapsed as a result of the intervention and the 
processes of randomisation, retention, assessment, and EFC intervention went largely 
smoothly, the feasibility and safety of a full-scale, comparable study set up RCT was 
supported by this pilot study (Arain et al., 2010). Including 6-months or more follow-ups, to 
measure longevity of effects, would be important. VH fears of participation could be 
addressed via written agreements with research sites to not automatically react with 
medication or hospital admissions should VH open up about their experience. The 
employment of research assistants could ensure a greater time commitment and thus more 
success in recruitment, the completion of assessments, and possible blinding.  
 
Clinical Implications 
This study provided an early promise of voice hearing, psychosis, non-shared reality and 
general psychopathology distress reducing effects of EFC, supported by a potential for EFC to 
facilitate trauma disclosure and the lessening of the chance element, despite psychotic 
spectrum diagnoses. Importantly, both research sites expressed interest in rolling out EFC 
further. These results thus support further large-scale RCTs and EFC’s potential application in 
psychiatric practice.  
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Table 1: EFC and TAU background characteristics 
Variable EFC (n=7) TAU (n=5) p (2-tailed): EFC vs TAU 
Age [mean (s.d.)] 44.14 (9.49) 40.20 (11.32) t=.656, df 10, p=.527 
Gender [n (%)]   x2=.010, df 1, p=.921  
   Female 3 (42.86) 2 (40.00)  
   Male 4 (57.14) 3 (60.00)  
Continous psychiatric contact, 
years [mean (s.d.)] 
18.29 (10.00) 18.20 (9.55) t=.015, df 10, p=.988 
Total admissions [n (s.d.)] 11.14 (7.31) 26.00 (19.01) t=-1.66, df 4.85, p=.159 
Primary diagnoses [n (%)]   x2= .779, df 1, p=.377 
   Schizophrenia 6 (285.71) 5 (100.00)  
   Schizoaffective disorder 1 (14.29) 0 (0)  
Time since diagnosis, years 
[mean (s.d.)] 
18.00 (7.66) 18.60 (9.21) t=-.123, df 10, p=.904 
Mean number antipsychotics 2 2.4  
Chlorpromazine equivalent 
dose* [mean in mg (s.d.)] 
958.78 (516.50) 915.50 (500.84)  t=.145, df 10, p=.888 
*Chlorpromazine equivalents were calculated using biomedcentral (Biomedcentral, 2013a;b) as a primary source, 
then Woods (2011) followed by Janssen, Weinmann, Berger & Gaebel (2004).  
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Table 2 – Primary Outcomes (Mean, standard deviation, within-group significance, treatment effect size) 
Outcome 
measure 
Baseline 3-months 6-months   44-weeks p (2-tailed) within-groups d (treatment effect size) (95% Confidence Intervals) 
 Mean (s.d.)  Mean (s.d.) Mean (s.d.) Mean (s.d.) 3-
months 
6-
months 
44-
weeks 
3-months 6-months 44-weeks 
BPRS-E           
   Total           
      EFC (n=7) 61.86  (15.08) 45.86 (12.77) 51.14 (12.81) 49.29 (12.31) .024*+ .166 .025*+ 1.7(0.32-3.06) 0.9(-0.31-2.12) 1.3(0.04-2.61) 
      TAU (n=5) 56.20 (16.16) 60.00 (16.31) 59.60 (15.69) 56.60 (12.76) .191 .486 .898    
BPRS-E           
   Psychosis           
      EFC  14.43 (4.50) 8.00 (4.83) 9.00 (4.87) 9.57 (4.79) .018*+ .046 .023*+ 1.5(0.17-2.82) 0.9(-0.37-2.05) 1.6(0.24-2.93)+ 
      TAU 12.00 (2.92) 12.80 (4.60) 13.40 (4.88) 13.80 (3.70) .374 .338 .221    
BPRS-E           
   Anx./Depr.           
      EFC 12.43 (4.39) 10.29 (3.45) 11.29 (3.40) 9.43 (3.60) .264 .550 .184 1.2(-0.11-2.40) 0.3(-0.83-1.49) 0.6(-0.55-1.81) 
      TAU 11.00 (5.24) 13.80 (2.28) 11.40 (2.88) 11.00 (3.81) .154 .840 1.00    
PSYRATS           
   Voices           
      EFC (n=7) 29.29 (4.86) 24.43 (7.28) 25.71 (8.90) 23.79 (11.63) .190 .452 .122 0.1(-1.01-1.29) 0.4(-0.78-1.53) 1(-0.28-2.16) 
      TAU (n=5) 26.00 (10.49 22.20 (15.82) 26.00 (10.12) 26.70 (10.88) .223 1.00 .578    
Anx./Depr. – anxiety and depression factor; BPRS-E – Brief Psychiatric Rating Scale – Expanded Version 4.0; d – Cohen’s effect sizes (1992): 0.2 – small; 0.5 – medium; 0.8 – large); EFC – 
Experience Focussed Counselling; n – sample size; p – statistical significance (set at 0.05); Psychosis – psychotic or positive symptoms factor; PSYRATS – Psychotic Symptom Rating Scales; s.d. – 
standard deviation; TAU – Treatment As Usual; Total – total scale – denoting overall psychopathology; Voices – voices aka auditory hallucinations scale; * - Achieved one-tailed significance for a 
priori directional hypotheses despite Bonferroni Correction; + - Achieved one-tailed power of β≥0.80;  
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